Ara
Toplam kayıt 3, listelenen: 1-3
Outcomes of the novolimus-eluting bioresorbable vascular scaffold in real world clinical practice
(Edizioni Minerva Medica, 2021)
BACKGROUND: Most of the current data regarding the use of bioresorbable scaffolds (BRS) come from everolimus-eluting stent platforms. Adverse events with the everolimus-eluting BRSs which are the most comprehensively ...
Is bioresorbable vascular scaffold acute recoil affected by baseline renal function and scaffold selection?
(Elsevier Ireland Ltd., 2016)
Objective: The aim of the present study was to investigate the relationship between glomerular filtration rate (GFR) and acute post-scaffold recoil (PSR) in patients undergoing bioresorbable scaffold (BVS) implantation. ...
Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?
(Turkish Society of Cardiology, 2021)
Objective: The data on using novolimus-eluting DESolve bioresorbable scaffolds (BVS) for long-segment coronary artery lesions remains insufficient. In this study, our main objective was to assess the long-term effects of ...